Milton Brown, MD, PhD

Turning a “Target” into a “Drug”

 

Milton L. Brown, MD, PhD, a well–known medicinal chemist, holds the Edwin H. Richard and Elisabeth Richard von Matsch Endowed Chair in Experimental Therapeutics at Georgetown University Medical Center. An experienced leader in establishing academic drug discovery centers, Brown received his PhD in synthetic chemistry at the University of Alabama at Birmingham, followed by an MD at the University of Virginia. As director of the Drug Discovery Program (DDP) at Georgetown University Medical Center he is positioned at the interface of chemistry and medicine to help facilitate the translation of basic science into new medical therapies. The DDP is currently involved in more than 20 drug discovery and development projects, in collaboration with investigators at Georgetown and other institutions.

Under Brown’s leadership, the DDP was selected as a Chemical Diversity Center in the National Cancer Institute’s Chemical Biology Program. He served as a member of both the Experimental Therapeutics and the Drug Discovery and Molecular Pharmacology study sections at NIH (2001–2006) and in the 2006 Breast Cancer Experimental Therapeutics study section at the Department of Defense. He also served for two years as an elected member of the medicinal chemistry long–range planning committee for the American Chemical Society.

« Previous Speaker | Next Speaker »